Loss of Protease-Activated Receptor 4 Prevents Inflammation Resolution and Predisposes the Heart to Cardiac Rupture After Myocardial Infarction

Mikhail A Kolpakov,Xinji Guo,Khadija Rafiq,Liudmila Vlasenko,Bahman Hooshdaran,Rachid Seqqat,Tao Wang,Xiaoxuan Fan,Douglas G Tilley,John C Kostyak,Satya P Kunapuli,Steven R Houser,Abdelkarim Sabri,Mikhail A. Kolpakov,Douglas G. Tilley,John C. Kostyak,Satya P. Kunapuli,Steven R. Houser
DOI: https://doi.org/10.1161/circulationaha.119.044340
IF: 37.8
2020-08-25
Circulation
Abstract:Background: Cardiac rupture is a major lethal complication of acute myocardial infarction (MI). Despite significant advances in reperfusion strategies, mortality from cardiac rupture remains high. Studies suggest that cardiac rupture can be accelerated by thrombolytic therapy, but the relevance of this risk factor remains controversial. Methods: We analyzed protease-activated receptor 4 (Par4) expression in mouse hearts with MI and investigated the effects of Par4 deletion on cardiac remodeling and function after MI by echocardiography, quantitative immunohistochemistry, and flow cytometry. Results: Par4 mRNA and protein levels were increased in mouse hearts after MI and in isolated cardiomyocytes in response to hypertrophic and inflammatory stimuli. Par4-deficient mice showed less myocyte apoptosis, reduced infarct size, and improved functional recovery after acute MI relative to wild-type (WT). Conversely, Par4 −/− mice showed impaired cardiac function, greater rates of myocardial rupture, and increased mortality after chronic MI relative to WT. Pathological evaluation of hearts from Par4 −/− mice demonstrated a greater infarct expansion, increased cardiac hemorrhage, and delayed neutrophil accumulation, which resulted in impaired post-MI healing compared with WT. Par4 deficiency also attenuated neutrophil apoptosis in vitro and after MI in vivo and impaired inflammation resolution in infarcted myocardium. Transfer of Par4 −/− neutrophils, but not of Par4 −/− platelets, in WT recipient mice delayed inflammation resolution, increased cardiac hemorrhage, and enhanced cardiac dysfunction. In parallel, adoptive transfer of WT neutrophils into Par4 −/− mice restored inflammation resolution, reduced cardiac rupture incidence, and improved cardiac function after MI. Conclusions: These findings reveal essential roles of Par4 in neutrophil apoptosis and inflammation resolution during myocardial healing and point to Par4 inhibition as a potential therapy that should be limited to the acute phases of ischemic insult and avoided for long-term treatment after MI.
cardiac & cardiovascular systems,peripheral vascular disease
What problem does this paper attempt to address?
The paper primarily explores the role of Protease-Activated Receptor 4 (PAR4) in the cardiac repair process after Myocardial Infarction (MI) and its impact on cardiac rupture. ### Research Background and Objectives - **Background**: Despite significant progress in reperfusion strategies, the mortality rate from cardiac rupture after myocardial infarction remains high. Studies suggest that thrombolytic therapy may accelerate the risk of cardiac rupture, but the correlation of this risk factor remains controversial. - **Objectives**: To investigate the expression of PAR4 in mice after myocardial infarction and to explore how the absence of PAR4 affects the repair process, cardiac function, and the occurrence of cardiac rupture after myocardial infarction. ### Main Findings 1. **PAR4 Upregulation**: After myocardial infarction, the mRNA and protein levels of PAR4 in the mouse heart increased; in vitro experiments also showed that under stress conditions, the expression of PAR4 in isolated cardiomyocytes increased. 2. **Acute Phase Role**: Mice lacking PAR4 exhibited less cardiomyocyte apoptosis, smaller infarct size, and better functional recovery during acute myocardial infarction compared to wild-type mice. 3. **Chronic Phase Impact**: However, during the chronic phase of myocardial infarction, PAR4-deficient mice showed exacerbated cardiac dysfunction, increased rates of myocardial rupture, and higher mortality. 4. **Inflammatory Mechanism**: The absence of PAR4 led to increased cardiac hemorrhage, delayed neutrophil accumulation, impaired inflammation resolution, and ultimately affected the healing process after myocardial infarction. 5. **Therapeutic Significance**: These findings reveal the critical role of PAR4 in neutrophil apoptosis and myocardial healing, suggesting that PAR4 inhibitors might serve as a new therapy to prevent early inflammation and cardiomyocyte loss. However, their application should be limited to the acute phase of ischemic injury to avoid chronic treatment. ### Conclusion - The study reveals the important role of PAR4 in the myocardial healing process, particularly its impact on neutrophil apoptosis and inflammation resolution. - It proposes that acute, transient PAR4 inhibitors might serve as a new method to prevent early inflammation after myocardial infarction. - Long-term or chronic use of PAR4 inhibitors may impair the myocardial healing process, increasing the risk of cardiac hemorrhage and myocardial rupture. - Therefore, the use of PAR4 inhibitors should be restricted to the acute phase of ischemic injury and avoided in long-term treatment after myocardial infarction.